within Pharmacolibrary.Drugs.J_AntiinfectivesForSystemicUse.J01C_BetaLactamAntibacterialsPenicillins.J01CA51_AmpicillinCombinations;

model AmpicillinCombinations
  extends Pharmacolibrary.Drugs.ATC.J.J01CA51;

  annotation (Documentation(
info       = "<html><body><table><tr><td>Drug:</td><td>J01CA51</td></tr><td>route:</td><td>intravenous</td></tr><tr><td>n-compartments</td><td>2</td></tr></table><p>Ampicillin in combination with other agents (such as sulbactam or flucloxacillin) is a broad-spectrum beta-lactam antibiotic used primarily for the treatment of a variety of infections including respiratory tract infections, urinary tract infections, meningitis, septicemia, endocarditis, and intra-abdominal infections. These combinations extend the spectrum of ampicillin by inhibiting beta-lactamases. Ampicillin and combinations are approved for medical use today, though they have been partially supplanted by other beta-lactams in resistant infections.</p><h4>Pharmacokinetics</h4><p>Pharmacokinetics reported for adult healthy subjects after intravenous administration of ampicillin/sulbactam combination.</p><h4>References</h4><ol><li><p>Dulhunty, JM, et al., &amp; Lipman, J (2024). Continuous vs Intermittent β-Lactam Antibiotic Infusions in Critically Ill Patients With Sepsis: The BLING III Randomized Clinical Trial. <i>JAMA</i> 332(8) 629–637. DOI:<a href=\"https://doi.org/10.1001/jama.2024.9779\">10.1001/jama.2024.9779</a>  PUBMED:<a href=\"https://pubmed.ncbi.nlm.nih.gov/38864155/\">https://pubmed.ncbi.nlm.nih.gov/38864155</a></p></li><li><p>Sullins, AK, &amp; Abdel-Rahman, SM (2013). Pharmacokinetics of antibacterial agents in the CSF of children and adolescents. <i>Paediatric drugs</i> 15(2) 93–117. DOI:<a href=\"https://doi.org/10.1007/s40272-013-0017-5\">10.1007/s40272-013-0017-5</a>  PUBMED:<a href=\"https://pubmed.ncbi.nlm.nih.gov/23529866/\">https://pubmed.ncbi.nlm.nih.gov/23529866</a></p></li><li><p>Maneerot, T, et al., &amp; Pattharachayakul, S (2025). Pharmacokinetics of intravenous piperacillin/tazobactam among patients with peritoneal dialysis-associated peritonitis. <i>Peritoneal dialysis international : journal of the International Society for Peritoneal Dialysis</i> 45(1) 57–61. DOI:<a href=\"https://doi.org/10.1177/08968608241241449\">10.1177/08968608241241449</a>  PUBMED:<a href=\"https://pubmed.ncbi.nlm.nih.gov/38666694/\">https://pubmed.ncbi.nlm.nih.gov/38666694</a></p></li></ol></body></html>",
    revisions  = "<html><body><ul><li>06/2025 initial model generated by LLM gpt-4.1 from general data</li></ul></body></html>",
    experiment (StartTime = 0, StopTime = 86400, Tolerance = 1e-9, Interval = 1)
  ));
end AmpicillinCombinations;
